Evidence Hub

Endocrine regulation of cardiac repolarization: early QTc shortening after testosterone in healthy AFAB adults

Tienforti D, Terrana G, Spagnolo L, Fusco B, Baroni MG, Barbonetti A

European journal of endocrinology, 2025

10 participants

Abstract

Testosterone modulates ventricular repolarization, yet the early time course of its effects in humans remains unclear. We conducted a prospective, single-center study in 10 healthy adults assigned female at birth initiating gender-affirming hormone therapy with daily transdermal testosterone gel. Standard 12-lead ECGs at baseline and 3 months showed no change in uncorrected QT, but significant QTc shortening by Bazett (-32 ms; P = .002) and Fridericia (-14 ms; P = .010) formulas, despite a concurrent heart rate reduction and with no association to changes in serum testosterone. These findings demonstrate rapid ventricular repolarization remodeling after testosterone initiation, with a magnitude comparable to the sex-based QTc gap. This study contributes to the characterization of early electrophysiologic adaptation to androgens in a standardized clinical model, and may inform cardiovascular monitoring strategies during abrupt hormonal transitions.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 10 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free